CXL treats radial keratotomy in the short-term

Article

Patients with radial keratotomy (RK) can be successfully treated with corneal cross-linking (CXL).

According to new results published in the journal Cornea patients with radial keratotomy (RK) can be successfully treated with corneal cross-linking (CXL).

The short-term case series, conducted by Dr Graciana Fuentes-Páez et al., Clinica Tacir-Centro Medico Teknon, Barcelona, Spain, featured seven eyes of four RK patients who underwent CXL with riboflavin and UV-A radiation.

Sphere, spherical equivalent (SE), uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), topographic astigmatism, mean topographic K (Km), pachymetry and Q values were all recorded 3 and 6 months after CXL.

After three months the findings revealed that the mean sphere of the patients was +1.0 ± 3.0 D, the astigmatism was 2.5 ± 1.2 D, SE was 0.3 ± 2.2 D and UCVA 0.41 ± 2.7. Additional findings showed that mean BSCVA was 0.80 ± 0.27, Km was 37.5 ± 5.7 D, pachymetry was 491 ± 33.74 μm and Q values were 2.27 ± 1.8.

Six months after CXL the findings improved further. Mean sphere was 0.53 ± 3.5 D, astigmatism was 1.62 ± 1.76 D, SE was 0.52 ± 2.9 D, UCVA was0.60 ± 2.0, BSCVA was 0.9 ± 0.15, Km was 38.3 ± 4.10 D, and Q values were 1.7 ± 0.78.

The data demonstrated a statistical and clinical significance in all areas on RK patients who underwent CXL.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.